Alkermes appoints Anne C. Whitaker to board, expanding to 11 directors

Alkermes plc.

Board increased from 10 to 11 directors; Whitaker effective Sept. 14, 2026, term through 2027 AGM.
Whitaker receives $600,000 initial equity award (50% options, 50% RSUs), vesting in 3 annual installments.
She will receive standard annual cash retainer and equity grant per proxy statement director compensation.
CEO Blair Jackson cites Whitaker's commercial and operational expertise in neuroscience-focused pipeline.
Chairman Richard Pops welcomes Whitaker, citing her CEO and board experience across pharma/biotech.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Anne C. Whitaker

Director

ALKS · Alkermes plc.

Effective: 2026-09-14
Filed: September 16, 2026, 9:12 AM ET

On September 14, 2026, the board of directors (the “Board”) of Alkermes plc (the “Company”) increased the size of the Board from ten (10) to eleven (11) directors and appointed Anne C. Whitaker to the Board, effective immediately, with an initial term expiring at the Company’s 2027 annual general meeting of shareholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anne C. Whitaker was appointed as Director at Alkermes plc..

Action: appointed
Role: Director

Exact text from the filing

On September 14, 2026, the board of directors (the “Board”) of Alkermes plc (the “Company”) increased the size of the Board from ten (10) to eleven (11) directors and appointed Anne C. Whitaker to the Board, effective immediately, with an initial term expiring at the Company’s 2027 annual general meeting of shareholders.

View on SEC.gov

Alkermes plc. filing history →

Source: SEC EDGAR

accession 0001193125-26-392527

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.